Low-dose aspirin to prevent postpartum breast cancer
Treatments studied
Part of Cancer, Skin clinical trials.
This study tests whether taking a low dose of aspirin after childbirth can lower the chance of developing breast cancer later. You may be asked to provide blood, urine, and breast tissue samples so researchers can look for changes that could explain why aspirin may help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You had a live birth within the last 10 years and are still having periods (not post-menopausal)
- You must be willing to sign consent and complete study questionnaires
- You must be willing to provide blood and urine samples and breast tissue samples at set times
- Your pregnancy test must be negative, and you must use contraception during treatment
- Recent lab tests must meet safety limits (enough blood counts, kidney function within limits)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether low-dose tamoxifen (a breast cancer prevention drug) or omega-3 supplements can lower breast cancer risk in postmenopausal women who are overweight and have a higher chance of getting the disease. The study lasts about 6 months and involves blood draws and a breast fluid test to see how the treatment affects breast cells.
This Phase 2 trial compares acolbifene and low-dose tamoxifen to see which better lowers breast cancer risk in premenopausal women at high risk. You would be followed with health visits, blood tests, and a breast tissue sampling procedure.
This study tests whether taking a low-dose aspirin daily can reduce inflammation and lower the risk of uterine (endometrial) cancer in postmenopausal women who have pelvic pain and certain uterine changes. If you qualify, you may receive either aspirin or a placebo (inactive pill) to see if aspirin helps.
This study tests whether taking a low dose of aspirin along with a stomach-protecting medicine (lansoprazole) can help prevent early birth in pregnant women who are at higher risk. It may reduce the chance of having your baby too early, which can be better for your baby's health.
This trial tests if taking aspirin after delivery helps prevent dangerous blood clots in women with certain risk factors. It's for new mothers who have a clotting disorder, were on bed rest, or have multiple other risk factors like high weight or preeclampsia.
This Phase 2 study tests whether starting low-dose aspirin after delivery can help people who had severe preeclampsia. The goal is to see if this treatment is safe and beneficial in the weeks after birth.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.